Literature DB >> 8793456

Right ventricular dysfunction in obstructive sleep apnoea: reversal with nasal continuous positive airway pressure.

J Nahmias1, R Lao, M Karetzky.   

Abstract

The incidence and pathogenesis of right ventricular dysfunction in obstructive sleep apnoea (OSA) remains controversial. Using nuclear ventriculography, the prevalence of right ventricular dysfunction (RVD) was therefore determined in obese patients with OSA, as well as their clinical characteristics, arterial blood gas values, spirometry and sleep parameters. The reversibility of RVD was evaluated after long-term use of nasal continuous positive airway pressure (nCPAP). We studied 112 obese patients with OSA by nuclear ventriculography, 35 with RVD (Group 1), 77 without RVD (Group 2), and 14 patients without OSA as controls (Group 3). Repeat nuclear ventriculography was performed in seven patients who used nCPAP nightly for 6-24 months. The mean right ventricular ejection fractions (RVEF) were 31%, 47% and 44% in Groups 1, 2 and 3, respectively. Group 1 also had a lower left ventricular ejection fraction (LVEF) of 55 vs 63% in Group 2. The OSA groups did not differ in mean spirometric or arterial blood gas values. Group 1 had a lower mean nocturnal arterial oxygen saturation (Sa,O2) of 82 vs 87% in Group 2, and a longer apnoea duration of 22.3 vs 19.2 s. All but two patients in Group 1 had either awake alveolar hypoventilation or an apnoea + hypopnoea index > 40 disordered breathing events.h-1. Repeat nuclear ventriculography after nCPAP revealed an increase in RVEF from 30 to 39%. In conclusion, right ventricular dysfunction is common in obstructive sleep apnoea, but it is reversible with nasal continuous positive airway pressure treatment and appears to be related to nocturnal oxygen desaturation.

Entities:  

Mesh:

Year:  1996        PMID: 8793456     DOI: 10.1183/09031936.96.09050945

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

1.  The impact of positive airway pressure on cardiac status and clinical outcomes in patients with advanced heart failure and sleep-disordered breathing: a preliminary report.

Authors:  Apostolos Karavidas; Fotis Kapsimalis; George Lazaros; Evaggelos Markozanes; Sophia Arapi; Kiriaki Cholidou; Vassiliki Matzaraki; Konstantina Kyrkou; Dimitris Tsiachris; Evaggelos Matsakas; Vlassios Pyrgakis; Manos Alchanatis
Journal:  Sleep Breath       Date:  2010-10-02       Impact factor: 2.816

Review 2.  Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology.

Authors:  Cyrus Kholdani; Wassim H Fares; Vahid Mohsenin
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

3.  Lower extremity edema and pulmonary hypertension in morbidly obese patients with obstructive sleep apnea.

Authors:  Daniel J O'Hearn; Avram R Gold; Morris S Gold; Paul Diggs; Steven M Scharf
Journal:  Sleep Breath       Date:  2008-07-10       Impact factor: 2.816

Review 4.  OSA: the new cardiovascular disease: part II: Overview of cardiovascular diseases associated with obstructive sleep apnea.

Authors:  Kiran Devulapally; Raymond Pongonis; Rami Khayat
Journal:  Heart Fail Rev       Date:  2008-08-29       Impact factor: 4.214

5.  Comparison of right ventricular functions by tissue Doppler imaging in patients with obstructive sleep apnea syndrome with or without hypertension.

Authors:  Yusuf Tavil; Asiye Kanbay; Nihat Sen; Tansu Ulukavak Ciftçi; Adnan Abaci; M Ridvan Yalçin; Oğuz Köktürk; Atiye Cengel
Journal:  Int J Cardiovasc Imaging       Date:  2006-10-20       Impact factor: 2.316

6.  Nocturnal Hypoxemia Impacts Right Ventricle Diastolic Function in Obstructive Sleep Apnea: A Retrospective Observational Study.

Authors:  Carla Scotti; Roberto Porta; Adriana Olivares; Laura Comini; Angelo Cinelli; Simonetta Scalvini; Michele Vitacca
Journal:  J Clin Med       Date:  2020-01-07       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.